RT220

GHS in the Laboratory Environment: Impacts and Opportunities

Tuesday, May 24 | 2:00 PM – 4:30 PM

Topics:

Emerging Markets/Global IH/OH Standards of Care, Laboratory Health and Safety

Arrangers: A. Mims, Eli Lilly & Company, Indianapolis, IN; J. Nesbitt, Mayo Clinic, Rochester, MN. Moderator: J. Peters, Brookhaven National Laboratory, Upton, NY. Monitors: G. Tomaszewski, Eli Lilly & Company, Indianapolis, IN; C. Davis, Eli Lilly & Company, Indianapolis, IN.

All provisions of the U.S. adoption of GHS will be fully enforceable as of June, 2016. During the transition, a large amount of learning and implementation has been accomplished, however; there is still work to be done. This collection of presentations has been developed with a focus on GHS in the laboratory environment. Challenges with implementation, solutions to common problems, and opportunities to transform the hazard communication process will be discussed.

The Impact of the GHS on the Lab Standard D. Deeds, Industrial Health & Safety Consultants, Inc., Shelton, CT.

Chemical Hazard Banding Using GHS Classification M. Squillace, Mayo Clinic, Rochester, MN.

GHS in NASA’s Research and Development Laboratories E. Lackey, NASA, Houston, TX.

GHS in NASA’s Research and Development Laboratories F. Calovini, NASA, Glenn Research Center, OH.

GHS and the GE Global Research Lab E. Leighton, GE Global Research, Niskayuna, NY.